AFMD Stock Price History and Quote Analysis: Insights for Investors

NASDAQ:AFMD

Affimed N.V.

$3.85

0.09+2.39%

Open: 11:03 AM

BESG ScoreESG Rating

profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Stock Price Today

Affimed N.V. (AFMD) stock surged +2.39%, trading at $3.85 on NASDAQ, up from the previous close of $3.76. The stock opened at $3.81, fluctuating between $3.77 and $3.85 in the recent session.

Stock Snapshot

3.76

Prev. Close

3.81

Open

58.63M

Market Cap

15.23M

Number of Shares

3.77

Day Low

3.85

Day High

-0.66

P/E Ratio

85.51%

Free Float in %

-5.83

EPS (TTM)

3.87

Book Value

-7.63

Cash Flow per Share

11.43K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 06, 2024	3.84	3.89	3.61	3.75	82.8K
Sep 05, 2024	3.93	3.94	3.61	3.78	137.45K
Sep 04, 2024	3.94	4.08	3.72	3.78	95.51K
Sep 03, 2024	4.27	4.27	3.90	3.95	75.38K
Aug 30, 2024	4.49	4.49	4.10	4.23	102.86K
Aug 29, 2024	4.16	4.51	4.14	4.42	80.6K
Aug 28, 2024	4.14	4.23	4.10	4.17	41.15K
Aug 27, 2024	4.22	4.33	4.10	4.17	35.95K
Aug 26, 2024	4.27	4.27	4.11	4.20	37.43K
Aug 23, 2024	4.14	4.25	4.11	4.21	67.1K
Aug 22, 2024	4.26	4.26	4.07	4.13	65.21K
Aug 21, 2024	4.31	4.35	4.15	4.26	66.1K
Aug 20, 2024	4.14	4.37	4.12	4.23	54.7K
Aug 19, 2024	3.98	4.16	3.95	4.14	40.06K
Aug 16, 2024	3.95	4.10	3.95	3.98	82.13K
Aug 15, 2024	4.04	4.09	3.90	3.97	74.7K
Aug 14, 2024	4.08	4.12	3.90	3.96	64.53K
Aug 13, 2024	4.09	4.22	4.09	4.10	18.03K
Aug 12, 2024	4.15	4.35	3.96	4.08	80.26K
Aug 09, 2024	4.22	4.25	3.89	4.10	105.23K

Contact Details

Heidelberg, 69120

Germany

Website: https://www.affimed.comContact: 496 221 674360

About Company

Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispecific epidermal growth factor receptor, and CD16A-binding innate cell engager, which is in Phase IIa clinical trial for the treatment of advanced cancers; AFM28, an innate cell engager (ICE), which is in preclinical development to treat acute myeloid leukemia; and AFM32, an ICE candidate that is in preclinical development for the treatment of solid tumors. Affimed N.V. has collaboration agreements with The University of Texas MD Anderson Cancer Center; Genentech, Inc.; and Roivant Sciences Ltd., as well as research funding agreement with The Leukemia & Lymphoma Society. The company was formerly known as Affimed Therapeutics B.V. and changed its name to Affimed N.V. in October 2014. Affimed N.V. was founded in 2000 and is headquartered in Heidelberg, Germany.

Frequently Asked Questions

What is the current Affimed N.V. (AFMD) stock price?

Affimed N.V. (NASDAQ: AFMD) stock price is $3.85 in the last trading session. During the trading session, AFMD stock reached the peak price of $3.85 while $3.77 was the lowest point it dropped to. The percentage change in AFMD stock occurred in the recent session was 2.39% while the dollar amount for the price change in AFMD stock was $0.09.

AFMD's industry and sector of operation?

The NASDAQ listed AFMD is part of Biotechnology industry that operates in the broader Healthcare sector. Affimed N.V. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of AFMD?

Dr. Wolfgang Fischer
MD, Chief Operating Officer & Member of Management Board
Mr. Alexander Fudukidis
Head of Investor Relations & Director of Investor Relations
Dr. Uwe Reusch
Head of Cell Culture
Dr. Arndt Justus Georg Schottelius M.D., Ph.D.
Chief Scientific Officer & Member of Management Board
Dr. Adi Hoess
Chief Executive Officer, MD & Member of Management Board
Ms. Denise Mueller
Chief Bus. Officer & Member of Management Board
Dr. Andreas Harstrick M.D.
Chief Medical Officer & Member of Management Board
Mary Beth Sandin
Vice President of Marketing & Communications
Prof. Melvyn Little
Founder & Consultant
Mr. Michael Wolf
Head of Fin. & Admin.
Dr. Arndt J. G. Schottelius M.D., Ph.D.
Chief Scientific Officer & Member of Management Board
Dr. Adi Hoess M.D., Ph.D.
Chief Executive Officer, MD & Member of Management Board
Mr. Angus W. Smith
Chief Financial Officer & Member of Management Board

How AFMD did perform over past 52-week?

AFMD's closing price is 67.86% higher than its 52-week low of $2.24 where as its distance from 52-week high of $8.95 is -57.99%.

How many employees does AFMD have?

Number of AFMD employees currently stands at 76.

Link for AFMD official website?

Official Website of AFMD is: https://www.affimed.com

How do I contact AFMD?

AFMD could be contacted at phone 496 221 674360 and can also be accessed through its website. AFMD operates from Technologiepark, Heidelberg, 69120, Germany.

How many shares of AFMD are traded daily?

AFMD stock volume for the day was 11.43K shares. The average number of AFMD shares traded daily for last 3 months was 187.92K.

What is the market cap of AFMD currently?

The market value of AFMD currently stands at $58.63M with its latest stock price at $3.85 and 15.23M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

Stock Price Today

Affimed N.V. (AFMD) stock surged +2.39%, trading at $3.85 on NASDAQ, up from the previous close of $3.76. The stock opened at $3.81, fluctuating between $3.77 and $3.85 in the recent session.

Stock Snapshot

3.76

Prev. Close

3.81

Open

58.63M

Market Cap

15.23M

Number of Shares

3.77

Day Low

3.85

Day High

-0.66

P/E Ratio

85.51%

Free Float in %

-5.83

EPS (TTM)

3.87

Book Value

-7.63

Cash Flow per Share

11.43K

Volume

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 06, 2024	3.84	3.89	3.61	3.75	82.8K
Sep 05, 2024	3.93	3.94	3.61	3.78	137.45K
Sep 04, 2024	3.94	4.08	3.72	3.78	95.51K
Sep 03, 2024	4.27	4.27	3.90	3.95	75.38K
Aug 30, 2024	4.49	4.49	4.10	4.23	102.86K
Aug 29, 2024	4.16	4.51	4.14	4.42	80.6K
Aug 28, 2024	4.14	4.23	4.10	4.17	41.15K
Aug 27, 2024	4.22	4.33	4.10	4.17	35.95K
Aug 26, 2024	4.27	4.27	4.11	4.20	37.43K
Aug 23, 2024	4.14	4.25	4.11	4.21	67.1K
Aug 22, 2024	4.26	4.26	4.07	4.13	65.21K
Aug 21, 2024	4.31	4.35	4.15	4.26	66.1K
Aug 20, 2024	4.14	4.37	4.12	4.23	54.7K
Aug 19, 2024	3.98	4.16	3.95	4.14	40.06K
Aug 16, 2024	3.95	4.10	3.95	3.98	82.13K
Aug 15, 2024	4.04	4.09	3.90	3.97	74.7K
Aug 14, 2024	4.08	4.12	3.90	3.96	64.53K
Aug 13, 2024	4.09	4.22	4.09	4.10	18.03K
Aug 12, 2024	4.15	4.35	3.96	4.08	80.26K
Aug 09, 2024	4.22	4.25	3.89	4.10	105.23K

Contact Details

Heidelberg, 69120

Germany

Website: https://www.affimed.comContact: 496 221 674360

About Company

Frequently Asked Questions

What is the current Affimed N.V. (AFMD) stock price?

AFMD's industry and sector of operation?

Who are the executives of AFMD?

How AFMD did perform over past 52-week?

AFMD's closing price is 67.86% higher than its 52-week low of $2.24 where as its distance from 52-week high of $8.95 is -57.99%.

How many employees does AFMD have?

Number of AFMD employees currently stands at 76.

Link for AFMD official website?

Official Website of AFMD is: https://www.affimed.com

How do I contact AFMD?

AFMD could be contacted at phone 496 221 674360 and can also be accessed through its website. AFMD operates from Technologiepark, Heidelberg, 69120, Germany.

How many shares of AFMD are traded daily?

AFMD stock volume for the day was 11.43K shares. The average number of AFMD shares traded daily for last 3 months was 187.92K.

What is the market cap of AFMD currently?

The market value of AFMD currently stands at $58.63M with its latest stock price at $3.85 and 15.23M of its shares outstanding.

Employees	76
Beta	2.11
Sales or Revenue	$8.28M
5Y Sales Change%	-0.859%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	76
Beta	2.11
Sales or Revenue	$8.28M
5Y Sales Change%	-0.859%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

AFMD Stock Price History and Quote Analysis: Insights for Investors

Affimed N.V.

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions

Stock Price Today

Stock Snapshot

Stock Price History Chart

Contact Details

About Company

Company Information

Frequently Asked Questions